Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout.
Fu-Shun YenChih-Cheng HsuHsin-Lun LiJames Cheng-Chung WeiChii-Min HwaPublished in: PloS one (2020)
Our study showed lower risks of hospitalized stroke and all-cause mortality in ULT users than in nonusers among patients with gout. Therefore, patients with gout may receive ULT to mitigate the risks of hospitalized stroke and mortality.